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Abstract 
The effects of chronic oral administration 
of a standardized Ginkgo biloba extract 
(GBE) on the performance of two 
classical memory tasks was investigated. 
Long-Evans rats, 3 and 16 months of age, 
received daily doses of diets with or 
without GBE (100 mg/kg) for a period of 6 
weeks before testing and throughout the 
experiment. A 2 x 2 (Age x Treatment) 
ANOVA indicated that GBE treatment 
prevented learning on a radial maze task 
as measured by number of days to 
criterion, F(1, 28) = 5.73, p < .05. A 2 x 2 
x 19 (Age x Treatment x Day) ANOVA was 
used to analyze the number of correct 
responses from Days 1 to 19. The results 
showed an interaction between Age and 
Treatment F(1, 28) = 6.34, p <. 05; 
namely young treated rats performed 
worse than other groups. Analysis of 
response frequency by a 2 x 2 (Age x 
Treatment) ANOVA revealed a significant 
interaction F(1, 28) = 4.41, p < .05, and 
a subsequent post hoc test indicated that 
the young treatment group responded 
notably more than the old groups. 
Measured performance on a one-way 
passive avoidance task indicated that 
neither treatment nor age had an effect. 
The results suggest that at the prescribed 
dose level and duration, GBE impairs 
performance on a radial maze task, 
particularly in young rats. 
The Ginkgo biloba tree is one of 
the oldest species of trees alive today. For 
over 5000 years, Chinese medicine has 
recognized the medicinal uses of Ginkgo 
biloba leaves to "benefit the brain" and 
allay a variety of pathological symptoms 
(Murray, 1990). Pharmacological and 
clinical studies published over the last few 
years have demonstrated the efficacy of a 
standardized Ginkgo biloba extract (GBE)  
for the treatment of a wide variety of age 
related conditions like edema, impotence, 
vertigo, tennitis, vigilance, and a number 
of pathologies associated with memory 
disorders. Currently, GBE is one of the 
most prescribed medicines in Europe for 
the treatment of pathological conditions. 
GBE's are made from the green 
leaves of the Ginkgo biloba tree. The 
active constituents of the standardized 
extracts include 24% glucoflavonoids, 6% 
terpenes (bilobalides and ginkgolides), 
and proanthocyanidies. Organic acids are 
added primarily to increase the 
compounds solubility and facilitate 
circulatory transportation to vital organs 
(Drieu, 1988). In regards to behavioral 
dysfunctions associated with memory, 
studies (e.g., Taylor, 1988) have 
suggested that GBE causes numerous 
morphological and biochemical changes 
in the brain which improve the memory of 
individuals suffering from Alzheimer's 
Disease, cerebral vascular insufficiency, 
and those affected by normal senescent 
memory loss. It is well known that 
memory dysfunctions result from a 
decline of cholinergic muscarinic activity 
in the hippocampus (Deutch, 1971; Gold 
& McGraugh, 1975). 
Numerous studies have cited 
similar declines in the brains of those 
suffering from forms of presenile and 
senile dementia (Bartus, Dean, Beer, & 
Lippa, 1982; Davis & Moloney, 1976). 
An inverse relationship between age and 
acetylcholine transmission has also been 
identified in animals and humans (Bartus 
et al., 1982; Taylor, 1988). Taylor has 
demonstrated that chronic oral 
administration of GBE increases the 
number of post-synaptic muscarinic 
acetylcholine receptors in the 
hippocampus regardless of age, but more 
so in aged rats. Cognitive deficits can also 
result from a reduction in cerebral blood 
flow, and GBE has been recognized for its 
ability to dilate arteries leading to the 
brain, thereby restoring cerebral 
circulation of glucose and oxygen which 
is essential for proper brain function 
(Karcher, Zageman, & Krieglstein, 1984; 
Rapin, Lamproglou, Dreiu, & Defeudis, in 
press). 
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Serotonin is another neuro-
transmitter that has been implicated as 
playing a critical role in memory; 
however, the correlation between 
serotonin levels and memory is less clear. 
In man and rodents, serotonin levels 
decrease in the cerebral cortex with age 
(Gottfries, 1979; Huguet, Drieu, & Piriou, 
1994). Lower serotoninergic activity has 
been identified as a major contributor to 
mood disorders like depression, which are 
more prevalent with age. Coupling the 
facts that one of the primary symptoms of 
depression is memory impairment, and 5-
HT-ergic agonists (e.g., tricyclics and 
MAO inhibitors) alleviate this symptom, 
the correlation between cerebral serotonin 
and memory appears to be positive. In this 
regard, recent studies by Huguet et al. 
(1994) demonstrated that treatment of 
GBE increases the number of 5-HT1A 
receptors of the cerebral cortex in 
senescent rats; nonsignificant increases in 
young rats were also found. 
Elucidation of the mechanisms by 
which GBE restores cerebral neuronal 
systems is not complete. Flavonoid 
derivatives are known to exhibit free 
radical scavenger activity which prevents 
lipid peroxidation of cell membranes 
(Pincemail & Deby, 1988). Neuronal 
membranes are uniquely more susceptible 
to peroxidation due to their high density 
of polyunsaturated fatty lipids. This 
scavenger activity alone maintains the 
relationship between neuronal membranes 
and receptors and also maintains 
membrane fluidity. Furthermore, it is 
believed that GBE enhances receptor 
density by restoring essential protein 
synthesis (Huguet et al., 1994). 
In addition to cerebral modulation, 
a few recent studies indicate that GBE 
affects the endocrine system by reducing 
plasma corticoids and catecholamines 
released by the adrenal cortex and 
medulla, respectively (Rapin et al., in 
press). Since elevated levels of these 
hormones are associated with anxiety-like 
activity and the disruption of learning 
performance (Hurwitz, Robinson, & 
Barofsky, 1971), GBE is said to exert 
"anti-stress" activity. By decreasing 
anxiety levels, GBE can prevent a 
number of maladaptive learning behaviors 
ranging from hyperactivity to an inability 
to make decisions (LePoncin, Aymonod, 
Brillon, Pesquies, & Rapin, 1980). In 
humans, the detrimental effects of anxiety 
are more pronounced in older subjects and 
can be particularly deleterious to learning. 
Clinical studies have demonstrated 
that chronic GBE treatment alleviates 
behavioral deficits associated with 
memory in individuals suffering from 
senility and many types of dementia 
(GeBner, Voelp, & Klasser, 1985;; 
Taillandier et al., 1988; Warburton, 1988). 
Most positive effects of GBE result after 
subjects receive treatment for at least 3-4 
weeks, and the duration of treatment is 
positively correlated with the beneficial 
effects (e.g., Taillandier et al., 1988). A 
smaller number of studies have shown that 
treatments can also improve the memory 
and performance on tasks in normal young 
volunteers (Subhan & Hindmach, 1984). 
Although many studies have 
examined the biochemical and 
morphological changes in rodents, few 
have investigated how these effects 
determine behavior. As a whole, the cited 
studies indicate that GBE primarily causes 
restorative physical changes in older 
subjects in biological systems important to 
the memory process. The present study 
was aimed at investigating the efficacy of 
chronic oral treatment of GBE on 
performance of memory tasks in young 
and old rats. Given this information, one 
would also expect to witness improved 
performance on memory tasks in older 
subjects. 
Experiment 1 
Method 
Subjects. The subjects were 32 
experimentally naive female Long-Evans 
rats weighing between 181-359 g at the 
beginning of the experiment and were 
classified as either young or aged, 
approximately 3 and 16 months old, 
respectively. Rats were housed separately 
on a 12 hr light-dark cycle in a 
temperature controlled room (23 °C). One 
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week prior to shaping, subjects were put 
on a 23 hr food deprivation schedule. 
Weights were monitored, and animals 
were given additional rations if their body 
weight fell below 85% of free-feeding 
weight. 
GBE Treatment. Six weeks prior 
to shaping, both young and aged rats were 
assigned to either an experimental or 
control group. The young experimental 
(YE) and old experimental (OE) groups 
were placed on a GBE-rich diet; each rat 
received 100 mg/kg of GBE daily. The 
supplement, marketed by Enzymatic 
Therapy®, is standardized to contain 24% 
Ginkgoheterosides. Weighed doses were 
masked in approximately 2 g of instant 
whipped potatoes and 0.2 g of sucrose. 
Young control (YC) and aged control 
(AC) groups received the potato-sucrose 
mixture without added GBE. Subjects 
were fed the supplement at 8:00 am daily 
for the duration of the experiment 
(approximately 11 weeks) and were 
weighed every third day to verify 
appropriate dose. Dose levels were based 
on previous studies (e.g., Taylor, 1988). 
Materials. The rats were tested on 
an elevated radial maze similar to the one 
described by Olton and Samuelson (1976). 
This apparatus has long been recognized 
as a valid tool for investigating the 
influence of pharmacological compounds 
on memory (Olton, 1987). The maze was 
elevated 94 cm above the floor. Each arm 
was 7 cm wide and extended 85 cm from 
the center platform; a 2.5 cm wall 
surrounded each arm, and a small cup was 
placed in each arm. An enclosed box over 
the center platform could be raised or 
lowered to control entry into all arms. The 
experimenter regulated this box from a 
separate room via a system of fishlines; 
rats were visually monitored by camera. 
Procedures. Each rat was 
randomly assigned four different arms 
which were baited at the beginning of 
each trial with two Bioserve® pellets. 
These assigned arms remained constant 
for each rat throughout shaping and test 
trails. Testing occurred 7 days a week 
between 2 p.m. - 6 p.m. The order of 
testing each group (i.e., YC, OC, YE, and 
OE) was rotated each day, and the maze 
was washed daily with dilute ammonia 
water at the end of testing. 
Shaping trials were conducted on 
Days 1-10, during which all cups (baited 
and nonbaited), were daily placed 
successively farther away from the central 
platform. Five Bioserve® pellets were 
placed in the arms with the baited cups; 
leading from the center platform to each 
cup. At the beginning of a trial, each 
animal was placed on the central platform 
under the enclosed box. When the box 
was raised, the rat was allowed to explore 
the maze for 3 min, during which the 
number of arm entries was recorded. The 
criterion for arm entry was placement of 
all 4 feet into an arm. On Days 5-10, 
subjects explored the maze for 3 min or 
until all arms were entered. Those subjects 
with fewer than two entries per session, 
were physically placed at various 
locations in the maze and encouraged to 
explore the maze. By Day 10 all rats were 
responding with approximately the same 
frequency. 
Testing was conducted from Day 
11-41. All cups were positioned at the 
distal end of each arm, and no Bioserve® 
tablets led to baited arms. Testing 
procedures were similar to shaping trials, 
however each rat was allowed only four 
arm entries; upon return to the central 
platform after the forth entry, the enclosed 
box was lowered. All subjects were tested 
from Days 11-30, during which the 
number of correct responses was recorded. 
The number of days to criterion for each 
individual subject was also recorded. A 
subject reached criterion when she made 
three of four correct responses for three 
consecutive days. After Day 30, testing 
continued only for those subjects who did 
not reach the criterion. By Day 41, all 
subjects had reached the criterion. 
Results 
Results from a 2 x 2 (Age x 
Treatment) analysis of variance on the 
response frequency during Days 1 to 5, 
demonstrated significant age effects, F(1, 
28) = 16.13, p < .001, and a significant 
interaction, F(1, 28) = 4.41, p < .05. Cell 
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means for the YC, YE, OC, and OE 
groups were 42.0, 59.6, 31.8, and 26.9, 
Figure I. Mean response frequencies during 
shaping phase of radial maze task. 
respectively (See Figure 1). A Scheffe 
post hoc test (p < .05) showed that the YE 
group response frequency was 
Figure 2. Mean number of days to criterion on 
radial maze task. 
significantly higher than the OE and OC, 
F(3, 28) = 7.26, p < .05. 
The mean number of days to 
criterion for each group is displayed in 
Figure 2. Means of 7.38 and 13.56 days, 
respectively, were needed for the control 
and experiment groups to reach criterion. 
A 2 x 2 (Age x Treatment) analysis of 
variance verified that the experimental 
group needed significantly more days than 
the control group to reach criterion, F(1, 
28) = 5.73, p < .05. The mean days to 
criterion for individual groups were as 
follows: YC, 4.88; YE, 15.50; OC, 9.88; 
and OE, 11.63. 
YC 	 YE 	 OC 
	 OE 
Figure 3. Overall mean number of correct 
responses per day during test phase of radial arm 
maze. 
Analysis of the number of correct 
responses from Days 1 to 19 was 
conducted by a 2 x 2 x 19 ( Age x 
Treatment x Day) split-plot analysis of 
variance. The results showed significant 
Figure 4. Mean number of correct responses 
during test phase of radial arm maze, Days 1 - 19. 
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treatment effects, F(1, 28) = 10.43, p < .01 
and a significant two-way interaction 
between age and treatment F(1, 28) = 
6.34, p < .05. Cell means for the YC, YE, 
OC, and OE groups were 3.06, 2.32, 2.73, 
and 2.64, respectively (See Figure 3). A 
Scheffe post hoc test (p < .05) showed that 
the YE group's average number of correct 
responses during the 19-day test period 
was significantly lower than the other 
three groups, F(2, 54) = 14.18, p < .001 
(See Figure 4). 
Discussion 
The results from the radial maze 
testing phase indicate that at the 
prescribed dose and treatment duration 
GBE clearly impaired learning. This is 
noted by the fact that as a combined 
group, both YE and OE took a 
significantly longer time to reach the 
criterion than the control groups. 
Although no significant interaction was 
calculated, the discrepancy between the 
number of days to criterion between the 
YE and YC was much larger than between 
OE and OC, suggesting that GBE had a 
more deleterious effect on the young rats 
than the old. Evaluation of the group 
performance over 19 days of testing 
concludes that the YE performed 
significantly worse than the other groups. 
This selective effect is contrary to 
expectations based on past studies which 
indicate that at this dose, critical 
biochemical and morphological changes 
occur primarily in old rats, which should 
theoretically improve memory and 
learning. 
A plausible explanation can be 
surmised if one takes into account the 
positive correlation between treatment and 
activity levels found in the young rats of 
this study. It is well established that the 
relationship between arousal and 
performance is curvilinear, and although a 
certain amount of arousal is required for 
the display of adaptive behaviors, too 
much arousal can lead to overactivity and 
poor performance. LePoncin et al. (1980) 
revealed that over arousal can also lead to 
hypoactivity and poor performance. This  
over arousal may explain why the OE 
group took longer to reach the criterion, 
and their response frequency tended to be 
lower than other groups. 
Another possible explanation for 
the adverse effects of treatments may be 
related to dose levels. As with any drug 
used to treat behavioral or physical 
problems, proper dose levels are critical 
for desired results; in fact, improper levels 
can cause adverse conditions. In this 
regard, studies that have found positive 
effects on elderly humans (e.g., 
Taillandier et al., 1988) have used daily 
doses ranging from 120-600 mg/day or 2-
12 mg/kg of body weight. In contrast, 
most studies on the biological effects of 
GBE in rats use a much higher dose of 
approximately 50-100 mg/kg of body 
weight. It is quite possible that although 
GBE had a restorative effect on neuronal 
systems known to be important in 
memory, excessive levels of GBE 
adversely affected other biological factors 
important for proper memory, 
performance functions, or both. 
Experiment 2 
Method 
Subjects. Same as Experiment 1. 
Testing of all subjects was conducted after 
completion of Experiment 1. One OE 
subject was euthanized prior to 
Experiment 2, due to rapid growth of a 
tumor which inhibited free mobility. 
GBE Treatment. The start of 
Experiment 2 was conducted 11 weeks 
after the experimental groups, YE and OE, 
were placed on treatment; treatment 
continued through Experiment 2. 
Materials. The second experiment 
was conducted with a one-way passive 
avoidance apparatus similar to one 
described by Ader, Weijnen, and 
Moleman (1972). The apparatus consisted 
of a 24 x 28 x 38 cm enclosed box and a 6 
x 24 cm elevated runway platform leading 
to a 6 x 6 cm opening into the box. 
Entrance into the box was controlled by a 
guillotine door. The runway was covered 
with wire mesh and the floor of the 
enclosed box was constructed with 4 mm 
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steel rods spaced 1.4 cm apart from each 
other. The box was elevated 94 cm above 
the floor and maintained in a dark room 
with the exception of a 40-W lamp fixed 
35 cm above the runway. 
Procedures. Testing was 
conducted over the course of two days. On 
the first day, each animal was separately 
placed in the box with the door closed for 
a period of 2 min. This was followed by a 
single trial in which the rat was placed on 
an elevated runway (facing opposite the 
door) and allowed to enter the box for 10 
s. Upon entry (4 feet on the interior grid 
floor), a guillotine door was lowered, 
leaving enough height for its tail. 
On Day 2, each rat was given three 
such trials, during which the latency to 
enter the box was recorded. Between 
trials, rats were placed in an adjacent cage 
for a 30 s intertrial interval. On the third 
of these trials, the rat received a single 1 s, 
0.50 mA electric shock through the grid 
floor of the cage immediately after 
entering. Shocks were produced by 25-V 
AC source delivered through a variable 
series resistor. Retention was tested when 
the rats were again placed on the elevated 
runway 30 s, 1 hr, and 20 hr after the 
shock trial. Subjects were allowed a 
maximum 120 s retention interval, and no 
shock was presented on retention trials. 
Results 
Two OC subjects refused to enter 
the darkened box when placed on the 
outside platform for preshock latency 
measurement, so their measurements 
could not be tabulated in the results. To 
control for differences in the preshock 
latency times, measurements of the 
postshock retention intervals were 
converted to proportions of retention by 
dividing the postshock latency minus 
preshock latency factor by 120 s minus 
preshock latency. All negative 
proportions, which resulted when 
postshock latencies were less than 
preshock latencies, were assigned a value 
of 0.0, since they reflected no retention. A 
2 x 2 x 3 (Age x Treatment x Time) 
between within split-plot analysis of 
variance was used to analyze the  
proportion of retained learning. 
Significance was reached for the main 
effect of Time, F(2, 50) = 34.93, p < .001. 
The proportion of retained learning for 
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Figure 5. Mean proportion of retained learning 
over trial intervals. 
each interval was as follows: 30 s .80; 1 hr 
.49; and 20 hr .19. A Scheffe post hoc test 
(p < .05) showed a significant difference 
in the proportions between all time 
intervals, F(2, 84) = 20.08, p < .001 (See 
Figure 5). Other main effects and 
interactions showed no significance. 
Discussion 
The significant differences in the 
proportions of retained learning suggest 
that over time, rats were less likely to 
remember the possible adverse effects of 
entering the dark box. Since no significant 
age differences were revealed between 
control groups in Experiment 1 or 
Experiment 2, one may conclude that 
either these tests are not sensitive to age 
differences in recall and memory or no 
memory differences exist between age 
groups. It is possible that at 16 months of 
age, the biological systems critical for 
proper memory function have not been 
significantly altered by the detrimental 
effects of aging. In fact, many of the 
studies investigating age differences in 
rats use subjects that are 18 months of age 
or older. 
MODERN PSYCHOLOGICAL STUDIES 	 69 
Scott Heldt 
General Discussion 
In conclusion, the present study 
suggests that repeated oral administration 
of a standardized GBE can have negative 
effects on the performance of a memory 
task in young and old rats. To date, no 
known studies have been published which 
demonstrate similar findings. In light of 
these results, it seems important that 
future studies determine the appropriate 
dose needed for positive results and the 
relationship between the morphological 
and biochemical modifications caused by 
GBE treatment and the resulting 
behavioral changes. 
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